Swiss Cancer Institute Patient Advisory Board

The Swiss Cancer Institute's Patient Advisor Board is much more than a symbolic committee – it is an active voice for those affected by cancer in oncological research. In recent interviews (Universimed, link below), members of the board provide insights into their roles and experiences.
What makes the Patient Advisory Board special? Its members – all of whom have been confronted with cancer themselves or through a family member – bring valuable perspectives to the planning and implementation of clinical trials. They ensure that trials are not only scientifically sound, but also patient-centered.
For example, the board reviews the comprehensibility of patient information, evaluates trial designs in terms of everyday reality, and makes recommendations for priorities. This ensures that patient focus is not an afterthought, but an integral part of the research process.

The Swiss Cancer Institute strongly supports this form of participation – because research that takes the needs of those affected seriously is not only ethical, but also scientifically stronger. It is a powerful model for participatory research – and a step toward greater transparency, quality, and relevance in cancer medicine.

Interviews & insights:

• Michale Emmenegger-Müller
• Ursula Ganz-Blättler
• Rosmarie Pfau